RhyGaze
Basel, Switzerland · $96.0M raised
- Headquarters
- Basel
- Business Model
- B2B
- Website
- rhygaze.com
- Total Funding
- $96.0M
- Last Round
- $86.0M Series AJan 2025
- Rounds
- 2
About
Gene therapy company focused on ophthalmology applications, based in Basel and Philadelphia.
Summary
RhyGaze is a Biotech company based in Basel, Switzerland. It has raised $96.0M in total across 2 rounds, most recently a $86.0M Series A round in Jan 2025. Investors include BioGeneration Ventures, GV and Novartis Venture Fund.
Tech & App Stack
1 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2025
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...